​
​

Sagimet Biosciences Ownership 2024 | Who Owns Sagimet Biosciences Now?

OverviewForecastRevenueFinancialsChart

Insider Ownership

14.11%

Sagimet Biosciences Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
BlackRock Health Sciences Trust II0.15%408,120408,120-Mar 31, 2024
BlackRock Health Sciences Trust0.09%21,96521,965-Mar 31, 2024
FIDELITY ADVISOR SERIES VII0.05%406,300--Jan 31, 2024
BRIDGEWAY FUNDS INC0.02%45,000--Mar 28, 2024
Federated Hermes Index Trust0.02%4,138--Jan 31, 2024
FIDELITY MT VERNON STREET TRUST0.01%389,439-659,342-62.87%Feb 29, 2024
FEDERATED HERMES INSURANCE SERIES0.01%24,0004,00020.00%Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%2,6572,122396.64%Mar 31, 2024
FIDELITY SECURITIES FUND0.00%384,900--Jan 31, 2024
VANGUARD INDEX FUNDS0.00%981,635628,422177.92%Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.00%1,198--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%130,06066,400104.30%Feb 29, 2024
Voya INVESTORS TRUST0.00%99,94899,948-Mar 31, 2024
Federated Hermes Equity Funds0.00%30,000-47,276-61.18%Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.00%9,109--Mar 31, 2024
SEASONS SERIES TRUST0.00%33,31833,318-Mar 31, 2024
VICTORY PORTFOLIOS0.00%34,1001400.41%Mar 31, 2024
BlackRock ETF Trust0.00%845845-Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%14,25913,2371295.21%Mar 31, 2024
USAA MUTUAL FUNDS TRUST0.00%93,69636,65664.26%Jan 31, 2024
SCHWAB CAPITAL TRUST0.00%12,562--Jan 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%9,6179,617-Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%56,6851,0761.93%Feb 29, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%1,3231,047379.35%Mar 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%13,60011,100444.00%Mar 31, 2024
Calvert Variable Products, Inc.0.00%525--Mar 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%84,08084,080-Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%1,5281,245439.93%Mar 31, 2024
NORTHERN FUNDS0.00%8,9616,344242.41%Mar 28, 2024
Global X Funds0.00%2,284--Jan 31, 2024
iSHARES TRUST0.00%788,934570,129260.56%Mar 31, 2024
BLACKROCK FUNDS0.00%302,930302,930-Feb 29, 2024
MUTUAL FUND SERIES TRUST0.00%185,000185,000-Mar 31, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%85,40178,4011120.01%Mar 31, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%3,4862,690337.94%Mar 31, 2024
ProFunds0.00%179133289.13%Mar 31, 2024
EQ ADVISORS TRUST0.00%16,2035,24147.81%Mar 31, 2024
PUTNAM ASSET ALLOCATION FUNDS0.00%402402-Feb 29, 2024
VANGUARD SCOTTSDALE FUNDS0.00%23,6692,85113.69%Feb 29, 2024
NATIONWIDE MUTUAL FUNDS0.00%98244382.19%Jan 31, 2024
VALIC Co I0.00%2,131612.95%Feb 29, 2024
PACIFIC SELECT FUND0.00%23,53521,373988.58%Mar 31, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%497--Feb 29, 2024
FIDELITY SALEM STREET TRUST0.00%14,70711,489357.02%Mar 31, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%7,5127,512-Mar 31, 2024
PROSHARES TRUST0.00%81311917.15%Feb 29, 2024
TIAA-CREF FUNDS0.00%7,575--Jan 31, 2024
SUNAMERICA SERIES TRUST0.00%629182.95%Jan 31, 2024
Bridge Builder Trust0.00%6,6305,001307.00%Mar 31, 2024
BlackRock Variable Series Funds, Inc.0.00%2,7372,024283.87%Mar 31, 2024

Sagimet Biosciences's largest mutual fund holder by % of total assets is "BlackRock Health Sciences Trust II", owning 408.12K shares, compromising 0.15% of its total assets.

Sagimet Biosciences Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 25, 2024Kemble Georgedirector, officer Executive ChairmanS-SaleSell23,625$3.17$74.83K118,693
Jul 23, 2024Martins Eduardo Brunoofficer Chief Medical OfficerS-SaleSell8,357$3.10$25.91K81,213
Jul 23, 2024Rozek Elizabethofficer General Counsel and CCOS-SaleSell10,914$3.10$33.83K160,506
Jul 23, 2024Kemble Georgedirector, officer Executive ChairmanS-SaleSell14,062$3.10$43.60K142,318
Mar 28, 2024Happel Daviddirector, officer President & CEOP-PurchaseBuy12,100$5.27$63.73K639,200

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 28, 2024Happel Daviddirector, officer President & CEOP-PurchaseBuy12,100$5.27$63.73K639,200

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 25, 2024Kemble Georgedirector, officer Executive ChairmanS-SaleSell23,625$3.17$74.83K118,693
Jul 23, 2024Martins Eduardo Brunoofficer Chief Medical OfficerS-SaleSell8,357$3.10$25.91K81,213
Jul 23, 2024Rozek Elizabethofficer General Counsel and CCOS-SaleSell10,914$3.10$33.83K160,506
Jul 23, 2024Kemble Georgedirector, officer Executive ChairmanS-SaleSell14,062$3.10$43.60K142,318
Apr 03, 2024Walbert Timothy Pdirector-Sell---2,200

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 05, 2024Jarrett Jenniferdirector-A-AwardBuy113,895$3.48$396.35K113,895
Aug 05, 2024Phillips Anne M.director-A-AwardBuy113,895$3.48$396.35K113,895
Aug 05, 2024Jarrett Jenniferdirector Buy----
Aug 05, 2024Phillips Anne M.director Buy----
Jul 25, 2024Kemble Georgedirector, officer Executive ChairmanS-SaleSell23,625$3.17$74.83K118,693
Jul 23, 2024Martins Eduardo Brunoofficer Chief Medical OfficerS-SaleSell8,357$3.10$25.91K81,213
Jul 23, 2024Rozek Elizabethofficer General Counsel and CCOS-SaleSell10,914$3.10$33.83K160,506
Jul 23, 2024Kemble Georgedirector, officer Executive ChairmanS-SaleSell14,062$3.10$43.60K142,318
Jun 07, 2024Walbert Timothy Pdirector-A-AwardBuy9,279$4.64$43.05K9,279
Jun 07, 2024SEIDENBERG BETH Cdirector-A-AwardBuy51,459$4.64$238.77K51,459
Jun 07, 2024Parsey Merdaddirector-A-AwardBuy51,459$4.64$238.77K51,459
Jun 07, 2024Hoelscher Paul W.director-A-AwardBuy9,279$4.64$43.05K9,279
Jun 07, 2024GRAMMER ELIZABETH Adirector-A-AwardBuy51,459$4.64$238.77K51,459
May 08, 2024Chauche Thierryofficer Chief Financial OfficerA-AwardBuy587,181$4.28$2.51M587,181
May 08, 2024Chauche Thierryofficer-Buy----
Apr 03, 2024Walbert Timothy Pdirector-A-AwardBuy73,014$5.23$381.86K73,014
Apr 03, 2024Hoelscher Paul W.director-A-AwardBuy73,014$5.23$381.86K73,014
Apr 03, 2024Walbert Timothy Pdirector-Sell---2,200
Apr 03, 2024Hoelscher Paul W.director Buy----
Mar 28, 2024Happel Daviddirector, officer President & CEOP-PurchaseBuy12,100$5.27$63.73K639,200

The last insider sell of Sagimet Biosciences's stock was made by Kemble George on Jul 25 2024, selling 23,625 shares at $3.17 per share (valued at $74.83K). The last insider buy of SGMT was made by Happel David on Mar 28 2024, buying 12,100 shares at $5.27 per share (worth $63.73K).

Sagimet Biosciences Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-4-
Q2 202481800.00%
Q1 202433100.00%
Q3 202351827.78%
Q1 2014-1-

0 total buy trades, and 4 total sell trades (buy/sell ratio of 0.00%) were made by Sagimet Biosciences's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-4-
Q2 2024---
Q1 20241--
Q3 202311100.00%
Q1 2014---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 4 open market sell trades of Sagimet Biosciences's stocks.

SGMT Ownership FAQ